IL-17RA Signaling in Prx1+ Mesenchymal Cells Influences Fracture Healing in Mice

Joseph L. Roberts,David Kapfhamer,Varsha Devarapalli,Hicham Drissi

DOI: https://doi.org/10.3390/ijms25073751

IF: 5.6

2024-03-29

International Journal of Molecular Sciences

Abstract:Fracture healing is a complex series of events that requires a local inflammatory reaction to initiate the reparative process. This inflammatory reaction is important for stimulating the migration and proliferation of mesenchymal progenitor cells from the periosteum and surrounding tissues to form the cartilaginous and bony calluses. The proinflammatory cytokine interleukin (IL)-17 family has gained attention for its potential regenerative effects; however, the requirement of IL-17 signaling within mesenchymal progenitor cells for normal secondary fracture healing remains unknown. The conditional knockout of IL-17 receptor a (Il17ra) in mesenchymal progenitor cells was achieved by crossing Il17raF/F mice with Prx1-cre mice to generate Prx1-cre; Il17raF/F mice. At 3 months of age, mice underwent experimental unilateral mid-diaphyseal femoral fractures and healing was assessed by micro-computed tomography (μCT) and histomorphometric analyses. The effects of IL-17RA signaling on the osteogenic differentiation of fracture-activated periosteal cells was investigated in vitro. Examination of the intact skeleton revealed that the conditional knockout of Il17ra decreased the femoral cortical porosity but did not affect any femoral trabecular microarchitectural indices. After unilateral femoral fractures, Il17ra conditional knockout impacted the cartilage and bone composition of the fracture callus that was most evident early in the healing process (day 7 and 14 post-fracture). Furthermore, the in vitro treatment of fracture-activated periosteal cells with IL-17A inhibited osteogenesis. This study suggests that IL-17RA signaling within Prx1+ mesenchymal progenitor cells can influence the early stages of endochondral ossification during fracture healing.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper primarily explores the role of the IL-17RA signaling pathway in Prx1+ mesenchymal cells and its impact on the fracture healing process in mice.

The core issue of the study is to understand whether and how the IL-17RA signaling pathway in Prx1+ mesenchymal cells affects the fracture healing process. By using a mouse model with conditional knockout of the Il17ra gene (which encodes the IL-17RA receptor), the researchers aim to reveal the mechanism of action of the IL-17RA signaling pathway in the early stages of fracture healing.

Specifically, the study found:

1. **Impact of Il17ra conditional knockout on bone microstructure**: In the uninjured state, Il17ra conditional knockout led to reduced cortical porosity in the femur of mice, but had little effect on most bone microstructure parameters. However, increased cortical thickness was observed in the lumbar vertebrae.

2. **Impact of Il17ra conditional knockout during fracture healing**:
- In the early stage of fracture (day 7), the bone content at the fracture site increased in Il17ra conditional knockout mice.
- However, by day 14, these mice showed increased cartilage and reduced bone tissue at the fracture site, indicating a delay in the cartilage-to-bone transition process.

3. **Effect of IL-17A on fracture-activated periosteal cells**:
- IL-17A can inhibit the osteogenic differentiation of fracture-activated periosteal cells from control mice, as evidenced by decreased expression of related genes and reduced mineralization.
- For periosteal cells from Il17ra conditional knockout mice, IL-17A had no significant effect.

4. **IL-17A promotes migration of fracture-activated periosteal cells**: In vitro experiments showed that IL-17A can significantly promote the migration of fracture-activated periosteal cells from control mice.

In summary, this study reveals that the IL-17RA signaling pathway in Prx1+ mesenchymal cells has a significant impact on fracture healing, and that IL-17A can inhibit osteogenic differentiation while promoting cell migration. These findings provide new insights into the molecular mechanisms of fracture healing.